Given their role in regulating gene expression, miRNAs are being explored as therapeutic targets. miRNA mimics or inhibitors (antagomirs) can be designed to modulate miRNA activity and, consequently, the expression of their target genes. This approach holds promise for the treatment of diseases such as cancer, where restoring the normal function of dysregulated miRNAs can inhibit tumor growth and progression.
